Healthcare provider profile · identity verified

Daryl Schroader, MD

Allopathic & Osteopathic Physicians|Internal Medicine · TUPELO, MS · NPI 1700841624

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Daryl Schroader, MD received $79.93 in general payments during 2025 across 4 reported records.

Dexcom, Inc. accounted for 43.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 111 claims for Eliquis by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$79.93

4 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Dexcom, Inc.	Unresolved — no canonical attribution shown	$34.72	43.4%	2	2025
Boston Scientific Corporation	Unresolved — no canonical attribution shown	$29.47	36.9%	1	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$15.74	19.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$79.93	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Dexcom G6 Transmitter Normalized: dexcom g6 transmitter	Medical Supply	Dexcom, Inc.	$34.72	2	2025
Source payment records 2025-06-04 · Dexcom, Inc. · $14.05 · Open Payments source 2025-12-29 · Dexcom, Inc. · $20.67 · Open Payments source
WATCHMAN FLX Normalized: watchman flx	Device	Boston Scientific Corporation	$29.47	1	2025
Source payment records 2025-09-30 · Boston Scientific Corporation · $29.47 · Open Payments source
ELIQUIS Normalized: eliquis	Drug	PFIZER INC.	$15.74	1	2025
Source payment records 2025-10-01 · PFIZER INC. · $15.74 · Open Payments source
NURTEC ODT Normalized: nurtec odt	Drug	PFIZER INC.	$15.74	1	2025
Source payment records 2025-10-01 · PFIZER INC. · $15.74 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
ELIQUIS eliquis	2025	Eliquis	2024	111	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	111	19

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1067	138
Atorvastatin Calcium	Atorvastatin Calcium	667	178
Amlodipine Besylate	Amlodipine Besylate	546	164
Gabapentin	Gabapentin	523	131
Potassium Chloride	Potassium Chloride	474	150
Lisinopril	Lisinopril	421	128
Losartan Potassium	Losartan Potassium	390	110
Pantoprazole Sodium	Pantoprazole Sodium	360	110
Metformin Hcl Er	Metformin Hcl	358	103
Furosemide	Furosemide	331	113
Allopurinol	Allopurinol	328	79
Carvedilol	Carvedilol	317	91
Pravastatin Sodium	Pravastatin Sodium	289	77
Omeprazole	Omeprazole	287	76
Levothyroxine Sodium	Levothyroxine Sodium	283	65
Metoprolol Succinate	Metoprolol Succinate	251	70
Albuterol Sulfate Hfa	Albuterol Sulfate	249	68
Hydrochlorothiazide	Hydrochlorothiazide	248	74
Trazodone Hcl	Trazodone Hcl	239	83
Venlafaxine Hcl Er	Venlafaxine Hcl	224	55
Fluticasone Propionate	Fluticasone Propionate	221	77
Ozempic	Semaglutide	220	44
Tramadol Hcl	Tramadol Hcl	217	46
Rosuvastatin Calcium	Rosuvastatin Calcium	200	61
Tizanidine Hcl	Tizanidine Hcl	200	56
Spironolactone	Spironolactone	197	56
Ezetimibe	Ezetimibe	196	62
Jardiance	Empagliflozin	180	53
Montelukast Sodium	Montelukast Sodium	179	48
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	168	22
Glimepiride	Glimepiride	153	45
Tamsulosin Hcl	Tamsulosin Hcl	150	48
Meloxicam	Meloxicam	138	54
Pregabalin	Pregabalin	134	32
Famotidine	Famotidine	127	39
Doxazosin Mesylate	Doxazosin Mesylate	122	35
Alprazolam	Alprazolam	121	15
Eliquis	Apixaban	111	19
Simvastatin	Simvastatin	105	26
Paroxetine Hcl	Paroxetine Hcl	102	34
Clopidogrel	Clopidogrel Bisulfate	101	34
Propranolol Hcl	Propranolol Hcl	98	21
Buspirone Hcl	Buspirone Hcl	92	24
Ropinirole Hcl	Ropinirole Hcl	92	19
Nabumetone	Nabumetone	91	31
Clonidine Hcl	Clonidine Hcl	90	26
Duloxetine Hcl	Duloxetine Hcl	90	24
Metoprolol Tartrate	Metoprolol Tartrate	85	27
Mounjaro	Tirzepatide	84	14
Linzess	Linaclotide	83	23
Esomeprazole Magnesium	Esomeprazole Magnesium	78	23
Alendronate Sodium	Alendronate Sodium	76	20
Diclofenac Sodium	Diclofenac Sodium	74	32
Isosorbide Mononitrate Er	Isosorbide Mononitrate	71	20
Clonazepam	Clonazepam	70	suppressed
Promethazine Hcl	Promethazine Hcl	70	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	18
Hydroxyzine Hcl	Hydroxyzine Hcl	65	19
Meclizine Hcl	Meclizine Hcl	65	27
Pioglitazone Hcl	Pioglitazone Hcl	65	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	65	21
Sertraline Hcl	Sertraline Hcl	64	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	19
Donepezil Hcl	Donepezil Hcl	62	24
Mirtazapine	Mirtazapine	62	21
Farxiga	Dapagliflozin Propanediol	61	22
Dicyclomine Hcl	Dicyclomine Hcl	59	17
Metformin Hcl	Metformin Hcl	58	19
Bupropion Hcl Sr	Bupropion Hcl	57	13
Citalopram Hbr	Citalopram Hydrobromide	56	14
Nitroglycerin	Nitroglycerin	56	24
Triamcinolone Acetonide	Triamcinolone Acetonide	56	25
Amitriptyline Hcl	Amitriptyline Hcl	52	18
Zolpidem Tartrate	Zolpidem Tartrate	51	12
Warfarin Sodium	Warfarin Sodium	50	suppressed
Fluconazole	Fluconazole	47	28
Ondansetron Hcl	Ondansetron Hcl	47	29
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	46	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	15
Oxybutynin Chloride Er	Oxybutynin Chloride	45	11
Tresiba Flextouch U-100	Insulin Degludec	45	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	38
Methocarbamol	Methocarbamol	42	18
Fenofibrate	Fenofibrate	41	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	12
Benazepril Hcl	Benazepril Hcl	39	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	31
Levetiracetam	Levetiracetam	38	suppressed
Lorazepam	Lorazepam	38	suppressed
Lovastatin	Lovastatin	38	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Ondansetron Odt	Ondansetron	37	17
Baclofen	Baclofen	36	suppressed
Colchicine	Colchicine	36	15
Doxycycline Hyclate	Doxycycline Hyclate	36	27
Hydroxyzine Pamoate	Hydroxyzine Pamoate	36	11
Valacyclovir	Valacyclovir Hcl	36	12
Januvia	Sitagliptin Phosphate	35	11
Midodrine Hcl	Midodrine Hcl	35	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	35	11
Repatha Sureclick	Evolocumab	35	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	27
Synthroid	Levothyroxine Sodium	34	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Irbesartan	Irbesartan	32	suppressed
Methylprednisolone	Methylprednisolone	32	30
Xarelto	Rivaroxaban	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Ibuprofen	Ibuprofen	31	suppressed
Lactulose	Lactulose	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	31	12
Valsartan	Valsartan	31	suppressed
Acarbose	Acarbose	30	suppressed
Nystatin	Nystatin	30	13
Trulicity	Dulaglutide	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Prednisone	Prednisone	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Spiriva Handihaler	Tiotropium Bromide	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Glipizide	Glipizide	24	suppressed
Torsemide	Torsemide	24	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	suppressed
Atenolol	Atenolol	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Dexlansoprazole Dr	Dexlansoprazole	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Pentoxifylline	Pentoxifylline	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Carbamazepine	Carbamazepine	21	suppressed
Estradiol	Estradiol	21	suppressed
Finasteride	Finasteride	21	suppressed
Levemir	Insulin Detemir	21	suppressed
Risperidone	Risperidone	21	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Mupirocin	Mupirocin	20	11
Topiramate	Topiramate	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Cephalexin	Cephalexin	18	12
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Propafenone Hcl	Propafenone Hcl	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Diazepam	Diazepam	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Cilostazol	Cilostazol	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Metolazone	Metolazone	14	suppressed
Modafinil	Modafinil	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Zaleplon	Zaleplon	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Alprazolam Er	Alprazolam	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Tiagabine Hcl	Tiagabine Hcl	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Dutasteride	Dutasteride	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$79.93 · 4 records	Dexcom, Inc.	Dexcom G6 Transmitter, ELIQUIS, NURTEC ODT, WATCHMAN FLX	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Eliquis play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error